Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.

Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma.

Shin HJ, Kim K, Lee JW, Song MK, Lee JJ, Lee HS, Lee WS, Kim SJ, Chung JS.

Eur J Haematol. 2014 Nov;93(5):414-21. doi: 10.1111/ejh.12377. Epub 2014 Jun 14.

PMID:
24813053
2.

Impact of extramedullary plasmacytomas on outcomes according to treatment approach in newly diagnosed symptomatic multiple myeloma.

Lee SE, Kim JH, Jeon YW, Yoon JH, Shin SH, Eom KS, Kim YJ, Kim HJ, Lee S, Cho SG, Lee JW, Min WS, Park CW, Min CK.

Ann Hematol. 2015 Mar;94(3):445-52. doi: 10.1007/s00277-014-2216-8. Epub 2014 Sep 26.

PMID:
25257340
3.

The t(11;14)(q13;q32) translocation as a poor prognostic parameter for autologous stem cell transplantation in myeloma patients with extramedullary plasmacytoma.

Shin HJ, Kim K, Lee JJ, Song MK, Lee EY, Park SH, Kim SH, Jang MA, Kim SJ, Chung JS.

Clin Lymphoma Myeloma Leuk. 2015 Apr;15(4):227-35. doi: 10.1016/j.clml.2014.12.007. Epub 2014 Dec 12.

PMID:
25812994
4.

Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.

Katodritou E, Terpos E, Symeonidis AS, Pouli A, Kelaidi C, Kyrtsonis MC, Kotsopoulou M, Delimpasi S, Christoforidou A, Giannakoulas N, Viniou NA, Stefanoudaki E, Hadjiaggelidou C, Christoulas D, Verrou E, Gastari V, Papadaki S, Polychronidou G, Papadopoulou A, Giannopoulou E, Kastritis E, Kouraklis A, Konstantinidou P, Anagnostopoulos A, Zervas K, Dimopoulos MA.

Am J Hematol. 2014 Aug;89(8):803-8. doi: 10.1002/ajh.23745. Epub 2014 May 12.

6.

Autologous stem cell transplantation: an effective salvage therapy in multiple myeloma.

Lemieux E, Hulin C, Caillot D, Tardy S, Dorvaux V, Michel J, Gastinne T, Rossi C, Legouge C, Touzeau C, Planche L, Loirat M, Lafon I, Moreau P.

Biol Blood Marrow Transplant. 2013 Mar;19(3):445-9. doi: 10.1016/j.bbmt.2012.11.013. Epub 2012 Nov 24.

7.

Radiotherapy for solitary plasmacytoma of bone and soft tissue: outcomes and prognostic factors.

Suh YG, Suh CO, Kim JS, Kim SJ, Pyun HO, Cho J.

Ann Hematol. 2012 Nov;91(11):1785-93. doi: 10.1007/s00277-012-1510-6. Epub 2012 Jun 30.

PMID:
22752147
8.

Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients.

Krejci M, Buchler T, Hajek R, Svobodnik A, Krivanova A, Pour L, Adam Z, Mayer J, Vorlicek J.

Bone Marrow Transplant. 2005 Jan;35(2):159-64.

PMID:
15543200
9.

Predictive value of post-transplant bone marrow plasma cell percent in multiple myeloma patients undergone autologous transplantation.

Hwang IH, Chung JS, Shin HJ, Choi YJ, Song MK, Seol YM, Cho GJ, Choi BG, Choi MK, Choi BK, Ahn KH, Shin KH, Lee HS, Nam HS, Hwang JM.

Korean J Intern Med. 2011 Mar;26(1):76-81. doi: 10.3904/kjim.2011.26.1.76. Epub 2011 Mar 2.

10.

Clinical features and prognostic factors in solitary plasmacytoma.

Finsinger P, Grammatico S, Chisini M, Piciocchi A, Foà R, Petrucci MT.

Br J Haematol. 2016 Feb;172(4):554-60. doi: 10.1111/bjh.13870. Epub 2015 Dec 18. Erratum in: Br J Haematol. 2016 Jul;174(2):336.

PMID:
26684545
11.

Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.

Kim JS, Kim K, Cheong JW, Min YH, Suh C, Kim H, Jo DY, Ryoo HM, Yoon SS, Lee JH; Korean Multiple Myeloma Working Party.

Biol Blood Marrow Transplant. 2009 Apr;15(4):463-70. doi: 10.1016/j.bbmt.2008.12.512.

12.

Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma.

Terpos E, Rezvani K, Basu S, Milne AE, Rose PE, Scott GL, Rahemtulla A, Samson D, Apperley JF.

Eur J Haematol. 2005 Nov;75(5):376-83.

PMID:
16191086
13.

Second autologous stem cell transplantation as salvage therapy for multiple myeloma: impact on progression-free and overall survival.

Jimenez-Zepeda VH, Mikhael J, Winter A, Franke N, Masih-Khan E, Trudel S, Chen C, Kukreti V, Reece DE.

Biol Blood Marrow Transplant. 2012 May;18(5):773-9. doi: 10.1016/j.bbmt.2011.10.044. Epub 2011 Nov 4.

14.

Molecular monitoring of minimal residual disease in the peripheral blood of patients with multiple myeloma.

Korthals M, Sehnke N, Kronenwett R, Schroeder T, Strapatsas T, Kobbe G, Haas R, Fenk R.

Biol Blood Marrow Transplant. 2013 Jul;19(7):1109-15. doi: 10.1016/j.bbmt.2013.04.025. Epub 2013 May 2.

15.

[Retrospective analysis on therapeutic effect of autologous hematopoietic stem cell transplantation in multiple myeloma patients].

Wang J, Fu CC, Wu DP, Sun AN, Xue SL, Xin X, Hu XH, Wang Y, Qiu HY, Jin ZM, Miao M, Tang XW, Han Y, Ma X, He GS, Chang WR, Chen SN.

Zhonghua Yi Xue Za Zhi. 2013 Jan 8;93(2):114-8. Chinese.

PMID:
23648347
16.

Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse.

Pour L, Sevcikova S, Greslikova H, Kupska R, Majkova P, Zahradova L, Sandecka V, Adam Z, Krejci M, Kuglik P, Hajek R.

Haematologica. 2014 Feb;99(2):360-4. doi: 10.3324/haematol.2013.094409. Epub 2013 Sep 13.

17.
18.

Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach.

Bladé J, Fernández de Larrea C, Rosiñol L, Cibeira MT, Jiménez R, Powles R.

J Clin Oncol. 2011 Oct 1;29(28):3805-12. doi: 10.1200/JCO.2011.34.9290. Epub 2011 Sep 6. Review.

PMID:
21900099
19.

Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma.

Dunavin NC, Wei L, Elder P, Phillips GS, Benson DM Jr, Hofmeister CC, Penza S, Greenfield C, Rose KS, Rieser G, Merritt L, Ketcham J, Heerema N, Byrd JC, Devine SM, Efebera YA.

Leuk Lymphoma. 2013 Aug;54(8):1658-64. doi: 10.3109/10428194.2012.751528. Epub 2012 Dec 31.

20.

Beta-2-microglobulin level predicts outcome following autologous hematopoietic stem cell transplantation in patients with multiple myeloma.

Stella-Holowiecka B, Czerw T, Holowiecka-Goral A, Giebel S, Wojnar J, Holowiecki J.

Transplant Proc. 2007 Nov;39(9):2893-7.

PMID:
18022010
Items per page

Supplemental Content

Write to the Help Desk